09:38 AM EST - Fennec Pharmaceuticals Inc. : Will release its full-year and fourth-quarter 2023 financial results before the opening of the U.S. financial markets on Thursday, March 21. Fennec Pharmaceuticals Inc.
shares T.FRX are trading unchanged at $13.18.
